Insiders · NBY

NBY insider transactions

NovaBay Pharmaceuticals Inc. (NBY) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for NBY

• 55d
  SEC Form 4 filed by Zheng Yenyou

  4 - Stablecoin Development Corp (0001389545) (Issuer)
• 56d
  SEC Form 4 filed by Law Tommy

  4 - Stablecoin Development Corp (0001389545) (Issuer)
• 61d
  SEC Form 4 filed by Kazley Michael John

  4 - Stablecoin Development Corp (0001389545) (Issuer)
• 62d
  SEC Form 4 filed by Sit Swan

  4 - Stablecoin Development Corp (0001389545) (Issuer)
• 125d
  Large owner Lazar David E. was granted 6,388,000 shares (SEC Form 4)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 211d
  Large owner Framework Ventures Iv L.P. converted options into 56,806,080 shares (SEC Form 4)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 211d
  Large owner R01 Fund Lp converted options into 56,806,080 shares (SEC Form 4)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 211d
  Chief Executive Officer Kazley Michael John converted options into 56,806,080 shares (SEC Form 4)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 223d
  Amendment: SEC Form 4 filed by Large owner Framework Ventures Iv L.P.

  4/A - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 223d
  Amendment: SEC Form 3 filed by new insider Framework Ventures Iv L.P.

  3/A - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 225d
  SEC Form 4 filed by Chief Executive Officer Kazley Michael John

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 225d
  SEC Form 4 filed by Large owner Framework Ventures Iv L.P.

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 225d
  SEC Form 4 filed by Large owner R01 Fund Lp

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 225d
  SEC Form 3 filed by new insider Kazley Michael John

  3 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 225d
  SEC Form 3 filed by new insider Framework Ventures Iv L.P.

  3 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 225d
  SEC Form 3 filed by new insider R01 Fund Lp

  3 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 229d
  SEC Form 4 filed by Large owner Lazar David E.

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 281d
  New insider Lazar David E. claimed no ownership of stock in the company (SEC Form 3)

  3 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 414d
  Large owner Poplar Point Capital Partners Lp bought $15,967 worth of shares (28,731 units at $0.56) (SEC Form 4)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 414d
  Large owner Poplar Point Capital Partners Lp bought $74,519 worth of shares (123,365 units at $0.60) (SEC Form 4)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 414d
  Large owner Poplar Point Capital Partners Lp bought $30,718 worth of shares (49,927 units at $0.62) (SEC Form 4)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 414d
  Large owner Poplar Point Capital Partners Lp bought $39,503 worth of shares (64,175 units at $0.62) (SEC Form 4)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 414d
  Large owner Poplar Point Capital Partners Lp bought $29,858 worth of shares (48,930 units at $0.61) (SEC Form 4)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 414d
  Large owner Poplar Point Capital Partners Lp bought $55,527 worth of shares (84,487 units at $0.66) (SEC Form 4)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 414d
  Large owner Poplar Point Capital Partners Lp bought $67,700 worth of shares (102,388 units at $0.66) (SEC Form 4)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 422d
  New insider Poplar Point Capital Partners Lp claimed ownership of 518,297 shares (SEC Form 3)

  3 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 733d
  SEC Form 4 filed by Garlikov Julie

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 733d
  SEC Form 4 filed by Freiman Paul E.

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 733d
  SEC Form 4 filed by Sit Swan

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 733d
  SEC Form 4 filed by Wu Mijia

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 733d
  SEC Form 4 filed by Zheng Yenyou

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 734d
  SEC Form 4 filed by Zheng Yongxiang

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1086d
  SEC Form 4 filed by Freiman Paul E.

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1086d
  SEC Form 4 filed by Garlikov Julie

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1086d
  SEC Form 4 filed by Zheng Yenyou

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1086d
  SEC Form 4 filed by Zheng Yongxiang

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1086d
  SEC Form 4 filed by Sit Swan

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1086d
  SEC Form 4 filed by Wu Mijia

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1115d
  SEC Form 4 filed by Freiman Paul E.

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1115d
  SEC Form 4 filed by Zheng Yenyou

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1115d
  SEC Form 4 filed by Wu Mijia

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1115d
  SEC Form 4 filed by Sit Swan

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1115d
  SEC Form 4 filed by Garlikov Julie

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1115d
  SEC Form 4 filed by Zheng Yongxiang

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1195d
  SEC Form 3: New insider Law Tommy claimed no ownership of stock in the company

  3 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1202d
  SEC Form 4 filed by Jones Andrew D.

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1274d
  SEC Form 4: Kunin Jeffrey sold $2 worth of shares (1 units at $1.81)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1274d
  SEC Form 4: Kunin Audrey sold $2 worth of shares (1 units at $1.81)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1276d
  SEC Form 4: Kunin Jeffrey sold $12,545 worth of shares (5,960 units at $2.10) (Amendment)

  4/A - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1276d
  SEC Form 4: Kunin Audrey sold $12,545 worth of shares (5,960 units at $2.10) (Amendment)

  4/A - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1288d
  SEC Form 4: Kunin Audrey sold $12,545 worth of shares (5,960 units at $2.10)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1288d
  SEC Form 4: Kunin Jeffrey sold $12,545 worth of shares (5,960 units at $2.10)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1356d
  SEC Form 4: Hall Justin bought $1,500 worth of shares (10,000 units at $0.15), increasing direct ownership by 14% to 83,172 units

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1356d
  SEC Form 4: Kunin Jeffrey sold $46,094 worth of shares (291,368 units at $0.16)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1356d
  SEC Form 4: Kunin Audrey sold $46,094 worth of shares (291,368 units at $0.16)

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1471d
  SEC Form 4: Wu Mijia converted options into 30,000 shares

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1471d
  SEC Form 4: Zheng Yenyou converted options into 30,000 shares

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1471d
  SEC Form 4: Freiman Paul E. converted options into 30,000 shares

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1471d
  SEC Form 4: Sit Swan converted options into 30,000 shares

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
• 1482d
  SEC Form 4 filed by Wu Mijia

  4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)